GlassScriptPhysician profile
Brittney Breanna Corniel
NPI 1033881057
$2,370.95
in general payments reported to CMS, 2019-2025
17 companies · $844 in 2025
The $844 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $10.93 · 2023: $462 · 2024: $1,054 · 2025: $844.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,360.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $569.98 | 2023-2025 | Wegovy, Ozempic |
| Gilead Sciences, INC. | $246.97 | 2023-2024 | Descovy |
| Hologic Sales and Service, LLC | $148.72 | 2025 | Aptima |
| Sanofi-Aventis U.S. LLC | $132.59 | 2024 | |
| Abbvie INC. | $124.99 | 2025 | |
| Mylan Specialty L.P. | $124.99 | 2024 | Yupelri |
| Phathom Pharmaceuticals, INC. | $121.98 | 2025 | Voquezna |
| Exact Sciences Corporation | $121.25 | 2023-2024 | Cologuard Collection Kit |
| Genzyme Corporation | $120.58 | 2024 | |
| Axsome Therapeutics, INC. | $119.70 | 2025 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $114.83 | 2025 | |
| Lilly USA, LLC | $113.40 | 2023 | Mounjaro |
| Neurelis, INC. | $108.61 | 2024 | Valtoco |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $97.48 | 2024 | |
| Janssen Pharmaceuticals, INC | $52.57 | 2025 | Spravato |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $41.38 | 2025 | |
| Inogen, INC. | $10.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittney Corniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.